We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
In the latest trading session, Doximity (DOCS - Free Report) closed at $61.09, marking a +1.13% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.52%. Meanwhile, the Dow gained 1%, and the Nasdaq, a tech-heavy index, added 0.52%.
The medical social networking site's stock has climbed by 16.31% in the past month, exceeding the Medical sector's gain of 3.5% and the S&P 500's gain of 5.95%.
The investment community will be closely monitoring the performance of Doximity in its forthcoming earnings report. The company is forecasted to report an EPS of $0.31, showcasing a 10.71% upward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $139.67 million, indicating a 10.26% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $1.46 per share and a revenue of $625.72 million, demonstrating changes of +2.82% and +9.7%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Doximity. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.5% higher. Doximity presently features a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Doximity has a Forward P/E ratio of 41.41 right now. This expresses a premium compared to the average Forward P/E of 32.04 of its industry.
It is also worth noting that DOCS currently has a PEG ratio of 4.49. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Medical Info Systems stocks are, on average, holding a PEG ratio of 2.75 based on yesterday's closing prices.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 74, this industry ranks in the top 31% of all industries, numbering over 250.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Doximity (DOCS) Laps the Stock Market: Here's Why
In the latest trading session, Doximity (DOCS - Free Report) closed at $61.09, marking a +1.13% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.52%. Meanwhile, the Dow gained 1%, and the Nasdaq, a tech-heavy index, added 0.52%.
The medical social networking site's stock has climbed by 16.31% in the past month, exceeding the Medical sector's gain of 3.5% and the S&P 500's gain of 5.95%.
The investment community will be closely monitoring the performance of Doximity in its forthcoming earnings report. The company is forecasted to report an EPS of $0.31, showcasing a 10.71% upward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $139.67 million, indicating a 10.26% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $1.46 per share and a revenue of $625.72 million, demonstrating changes of +2.82% and +9.7%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Doximity. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.5% higher. Doximity presently features a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Doximity has a Forward P/E ratio of 41.41 right now. This expresses a premium compared to the average Forward P/E of 32.04 of its industry.
It is also worth noting that DOCS currently has a PEG ratio of 4.49. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Medical Info Systems stocks are, on average, holding a PEG ratio of 2.75 based on yesterday's closing prices.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 74, this industry ranks in the top 31% of all industries, numbering over 250.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.